Nektar Therapeutics (NKTR)
NASDAQ: NKTR
· Real-Time Price · USD
8.56
-0.20 (-2.28%)
At close: Jun 13, 2025, 3:59 PM
8.70
1.58%
After-hours: Jun 13, 2025, 07:18 PM EDT
Nektar Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| License Collaboration And Other Revenue Revenue | 597K | 520K | 1.91M | 436K | 55.85M | 16.98M | 33.31M |
| License Collaboration And Other Revenue Revenue Growth | +14.81% | -72.82% | +338.76% | -99.22% | +229.01% | -49.04% | n/a |
| Non Cash Royalty Revenue Related To Sale Of Future Royalties Revenue | 64.27M | 68.92M | 69.79M | 77.75M | 48.56M | 36.3M | n/a |
| Non Cash Royalty Revenue Related To Sale Of Future Royalties Revenue Growth | -6.75% | -1.25% | -10.23% | +60.09% | +33.77% | n/a | n/a |
| Product Revenue | 33.56M | 20.68M | 20.35M | 23.73M | 17.5M | 20.12M | n/a |
| Product Revenue Growth | +62.29% | +1.64% | -14.23% | +35.54% | -12.99% | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 97.05M | 78.64M | 82.21M | 91.79M | 87.95M | 87.52M | 1.09B | 190.81M | 39.15M | 32.51M |
| Non-Us Revenue Growth | +23.41% | -4.35% | -10.44% | +4.37% | +0.49% | -91.98% | +471.67% | +387.42% | +20.40% | n/a |
| United States Revenue | 1.38M | 11.48M | 9.84M | 10.11M | 64.97M | 27.09M | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -88.02% | +16.66% | -2.70% | -84.43% | +139.79% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 24.35M | 17.14M | 18.96M | 20.51M | 20.15M | 17.32M | 21.15M | 17.87M | 21.08M | 21.94M | 22.53M | 20.52M | 27.34M | 32.14M | 29.47M | 29.55M | 31.68M | 27.14M | 26.98M | 24.35M | 26.22M | 27.14M | 23.98M | 22.58M | 25.01M | 23.78M | 18.72M | 20.26M | 18.69M | 12.34M | 12.05M | 16M | 11.98M | 12.76M | 10.25M | 11.04M | 10.23M | 13.23M | 9.54M | 10.18M | 10.3M |
| Selling, General, and Administrative Revenue Growth | +42.08% | -9.61% | -7.57% | +1.79% | +16.33% | -18.10% | +18.34% | -15.24% | -3.91% | -2.64% | +9.81% | -24.94% | -14.94% | +9.07% | -0.29% | -6.70% | +16.74% | +0.57% | +10.82% | -7.13% | -3.41% | +13.17% | +6.21% | -9.70% | +5.17% | +27.03% | -7.62% | +8.42% | +51.47% | +2.34% | -24.64% | +33.57% | -6.14% | +24.45% | -7.09% | +7.89% | -22.72% | +38.67% | -6.28% | -1.16% | n/a |
| Research and Development Revenue | 30.48M | 28.75M | 35.03M | 29.72M | 27.41M | 29.94M | 24.07M | 29.68M | 30.47M | 34.74M | 33.59M | 42.74M | 107.25M | 99.61M | 103.74M | 101.31M | 95.6M | 102.72M | 100.53M | 96.44M | 108.99M | 110.37M | 99.05M | 106.69M | 118.46M | 108.88M | 102.89M | 88.33M | 99.42M | 81.43M | 65.71M | 60.26M | 61.06M | 50.23M | 51.95M | 52.35M | 49.27M | 47.13M | 43.23M | 45.41M | 47.01M |
| Research and Development Revenue Growth | +6.04% | -17.94% | +17.85% | +8.45% | -8.46% | +24.40% | -18.90% | -2.59% | -12.29% | +3.42% | -21.41% | -60.15% | +7.67% | -3.98% | +2.39% | +5.97% | -6.93% | +2.18% | +4.25% | -11.52% | -1.25% | +11.43% | -7.16% | -9.94% | +8.80% | +5.82% | +16.48% | -11.15% | +22.10% | +23.91% | +9.05% | -1.31% | +21.55% | -3.31% | -0.76% | +6.26% | +4.53% | +9.04% | -4.81% | -3.40% | n/a |